Elsevier

Immunobiology

Volume 198, Issues 1–3, December 1997, Pages 124-135
Immunobiology

The Transcriptional Activation Pattern of Lipopolysaccharicle Binding Protein (LBP) Involving Transcription Factors AP-1 and C/EBPβ

https://doi.org/10.1016/S0171-2985(97)80033-2Get rights and content

Abstract

Lipopolysaccharide (LPS) Binding Protein (LBP) is an acute phase protein with the ability to recognize bacterial LPS and transport it to the CD14 molecule or into HDL particles. It is synthesized in hepatocytes and secreted into the blood stream. LBP levels significantly rise during the acute phase response and levels of LBP may be important for an appropriate host reaction to bacterial challenge and for developing the sepsis syndrome. In order to elucidate the mechanisms of LBP regulation we investigated its transcription pattern and performed promoter studies under experimental conditions mimicking an acute phase scenario. In human hepatoma cell lines stimulation with IL-1β, IL-6, TNF-α and dexamethasone leads to strong transcriptional activation of the LBP gene in a dose- and time-dependent manner. IL-6 alone induces LBP significantly, whereas IL-1β mainly increases the IL-6 effect when applied in combination. Our results furthermore show that AP-1 and C/EBPβ are transcription factors involved in the activation of the LBP gene, as revealed by Luciferase reporter gene analysis and electromobility shift assays. Elucidating the mechanism of transcriptional activation of LBP potentially may help in understanding host-pathogen response patterns and mechanisms involved in the acute phase reaction and in the pathophysiology of sepsis.

References (33)

  • TobiasP. et al.

    Isolation of a Lipopolysaccharide-Binding Acute Phase Reactant from rabbit serum

    J. Exp. Med.

    (1986)
  • SchumannR.R. et al.

    LPS Binding Protein (LBP) is a secretory class 1 acute phase protein, that is transcriptionally activated, involving STAT-3 and othercytokine-induced nuclear proteins

    Mol. Cell Biol.

    (1996)
  • FreyE.A. et al.

    Soluble CD14 participates in the response of cells to lipopolysaccharide

    J. Exp. Med.

    (1992)
  • PuginJ. et al.

    Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lip opolysaccharide-binding protein and soluble CD14

    Proc. Natl. Acad. Sci. U.S.A.

    (1993)
  • HanJ. et al.

    A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells

    Science

    (1994)
  • WeinsteinS.L. et al.

    Bacterial lipopolysaccharide stimulates protein tyrosine phoshorylation in macrophages

    Proc. Natl. Acad. Sci. U.S.A.

    (1991)
  • Cited by (24)

    • Quantitative indices of dynamics in concentrations of lipopolysaccharide-binding protein (LBP) as prognostic factors in severe sepsis/septic shock patients - Comparison with CRP and procalcitonin

      2011, Clinical Biochemistry
      Citation Excerpt :

      Nevertheless, some of biomarkers are commonly assessed in clinical practice, lipopolysaccharide-binding protein (LBP) among them. LBP is a liver-synthesized glycoprotein belonging to the first class of acute phase proteins, the expression of which is triggered by synergistic activity of interleukins (IL) 1 and 6 [6,7]. It seems to play a double role in inflammation by enhancing host response to lipopolysaccharide (LPS) challenge at physiologically low concentrations but conferring protection against effects exerted by LPS at high concentrations, present during acute phase [8,9].

    • Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation

      2008, Blood
      Citation Excerpt :

      This finding provides novel insight into the complex biology of the innate immune response to LPS and GN infections. LBP is a secretory class I acute-phase protein, whose gene is transcriptionally activated by APRF/STAT3 and other cytokine-inducible nuclear proteins, such as AP-1 and C/EBPβ.10,29 Transcription of the LBP gene is also induced by IL-1β alone, synergistically by IL-1β and IL-6, or by tumor necrosis factor-α and dexamethasone, resulting in maximal circulating LBP concentrations within 24 to 48 hours after LPS challenge.30,31

    • Ethanol consumption decreases the synthesis of the mannose 6-phosphate/insulin-like growth factor II receptor but does not decrease its messenger RNA

      2003, Biochemical Pharmacology
      Citation Excerpt :

      Both the elevation and decline of the latter mRNAs by ethanol occur with a concomitant increase or decrease in the proteins they encode [21,30–32]. Nuclear run-on assays and mRNA half-life studies showed that the ethanol-elicited increase in LBP mRNA level is due to activation of transcription factors AP-1 and C/EBP-β as well as to ethanol-elicited LBP mRNA stabilization [33,34]. The mechanisms for the ethanol-induced reduction of ASGPR mRNA and the elevation of TGF-β1 mRNA are not known.

    • Localization of regulatory elements mediating constitutive and cytokine-stimulated plasminogen gene expression

      2002, Journal of Biological Chemistry
      Citation Excerpt :

      Two possible candidates for transcriptional repressors are octamer factor 1 (Oct-1) and activator protein 1 (AP-1). Oct-1 and AP-1 are ubiquitously expressed and both can function as either activators or repressors of transcription (40-44). Similarly, removal of the homologous region on the human plasminogen gene (−709 to −515 bp) resulted in a modest increase in luciferase activity suggesting the presence of a repressor within this region as well (Fig.5 B).

    View all citing articles on Scopus
    1

    R. R. Schumann, M.D., Institute of Microbiology, University Medical Center ≪Charité≫,Humboldt-University, Dorotheenstraße 96, D-10117 Berlin, Germany, Phone: +49-30-9406-3849, Fax: +49-30-9406-3532, e-mail: [email protected]

    View full text